AbbVie’s Parkinson’s disease drug meets main goal in late-stage trial
(Reuters) -AbbVie’s drug met the main goal in a late-stage trial when tested in patients with early Parkinson’s disease, the company said
(Reuters) -AbbVie’s drug met the main goal in a late-stage trial when tested in patients with early Parkinson’s disease, the company said
This article summarizes the most significant insider buy and sell transactions for US stocks reported on Wednesday, September 25, 2024. Top Insider Buys: •
By Nate Raymond and Dietrich Knauth (Reuters) – The U.S. Senate voted to hold Steward Health Care CEO Ralph de la Torre in
By Ross Kerber and Isla Binnie (Reuters) – Moving money from coal assets to a new responsible-investment exchange-traded vehicle provided the sort of
Investing.com — Mirion Technologies shares gained over 3% on Thursday following a new Buy rating from B. Riley, with a price target
By Jarrett Renshaw ERIE, Pennsylvania (Reuters) – Drillers in energy-rich Pennsylvania this week called on Democratic presidential candidate Kamala Harris to detail her
(Removes double reference to official’s title) LONDON (Reuters) – At least five African countries are working on what could be the world’s first
(Reuters) – Airlines in the United States have canceled or delayed thousands of flights on Thursday, as a strengthening hurricane Helene is
By Pranav Kashyap and Shashwat Chauhan (Reuters) -European shares jumped on Thursday, with China-exposed stocks such as luxury and miners outperforming on news
By Ricardo Brito BRASILIA (Reuters) -Elon Musk-owned social media platform X has requested Brazil’s Supreme Court to allow it to resume service in